Sweden Multiomics Market Size & Outlook, 2026-2033
The multiomics market in Sweden is expected to reach a projected revenue of US$ 121.8 million by 2033. A compound annual growth rate of 12.7% is expected of Sweden multiomics market from 2026 to 2033.
In terms of revenue, Sweden accounted for 1.5% of the global multiomics market in 2025.
Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
In Europe, UK multiomics market is projected to lead the regional market in terms of revenue in 2033.
UK is the fastest growing regional market in Europe and is projected to reach USD 1,008.9 million by 2033.
Sweden’s robust research community has been actively engaged in multiomics research, making substantial investments in cutting-edge technologies that harness genomics, transcriptomics, proteomics, and metabolomics to deepen the understanding of biological systems.
For instance, in December 2021, Swedish scientists released a high-resolution single-cell transcriptomic map of human tissues, a significant discovery with the potential to advance diagnostics and medical laboratory testing.
Similarly, in April 2022, the Danish National Genome Center and Genomic Medicine Sweden entered into a partnership to develop advanced precision medicine. This initiative aims to develop and implement novel solutions and models to deliver genomic-based precision medicine at the national level.
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Multiomics Market Outlook will help companies and investors design strategic landscapes.
Bulk Multiomics was the largest segment with a revenue share of 76.39% in 2025.
Horizon Databook has segmented the Sweden multiomics market based on single-cell multiomics, bulk multiomics covering the revenue growth of each sub-segment from 2021 to 2033.
Sweden’s robust research community has been actively engaged in multiomics research, making substantial investments in cutting-edge technologies that harness genomics, transcriptomics, proteomics, and metabolomics to deepen the understanding of biological systems.
For instance, in December 2021, Swedish scientists released a high-resolution single-cell transcriptomic map of human tissues, a significant discovery with the potential to advance diagnostics and medical laboratory testing.
Similarly, in April 2022, the Danish National Genome Center and Genomic Medicine Sweden entered into a partnership to develop advanced precision medicine. This initiative aims to develop and implement novel solutions and models to deliver genomic-based precision medicine at the national level.
Sweden Multiomics Market Type Outlook (Revenue, USD Million , 2021-2033)
Single-cell Multiomics
Bulk Multiomics
Sweden Multiomics Market Platform Outlook (Revenue, USD Million , 2021-2033)
Genomics
Transcriptomics
Proteomics
Metabolomics
Integrated Omics Platforms
Sweden Multiomics Market Product & Service Outlook (Revenue, USD Million , 2021-2033)
Services
Product
Sweden Multiomics Market End Use Outlook (Revenue, USD Million , 2021-2033)
Pharmaceutical & Biotechnology Companies
Others
Academic & Research Institutes
Sweden Multiomics Market Application Outlook (Revenue, USD Million , 2021-2033)
Immunology
Cell Biology
Oncology
Neurology
Reasons to subscribe to Multiomics Market Outlook databook
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Multiomics Market Outlook databook
Our clientele includes a mix of Multiomics Market Outlook companies, investment firms, advisory firms & academic institutions.
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Sweden Multiomics Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into Sweden Multiomics Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.